CAZypedia needs your help!
We have many unassigned pages in need of Authors and Responsible Curators. See a page that's out-of-date and just needs a touch-up? - You are also welcome to become a CAZypedian. Here's how.
Scientists at all career stages, including students, are welcome to contribute.
Learn more about CAZypedia's misson here and in this article.
Totally new to the CAZy classification? Read this first.

Difference between revisions of "Glycoside Hydrolase Family 38"

From CAZypedia
Jump to navigation Jump to search
m
Line 25: Line 25:
 
== Substrate specificities ==
 
== Substrate specificities ==
 
GH38 enzymes are Class II &alpha;-mannosidases. They range in breadth of specificity from the Golgi &alpha;-mannosidase (2A1), which has a dual specificity for &alpha;1,6 and &alpha;1,3-linked mannoses, to the lysosomal mannosidases, which have either broad (2B1 cleaves &alpha;1,2, &alpha;1,3 and &alpha;1,6 linkages) or narrow specificities (2B2 is specific for &alpha;1,6). GH38 active sites can be quite long and open, and some are sensitive to the polysaccharide substrate structure. For example, Golgi &alpha;-mannosidase II requires the presence of a GlcNAc residue some five residues away from the cleavage site, while lysosomal mannosidases do not have that requirement <cite>1 11</cite>.  
 
GH38 enzymes are Class II &alpha;-mannosidases. They range in breadth of specificity from the Golgi &alpha;-mannosidase (2A1), which has a dual specificity for &alpha;1,6 and &alpha;1,3-linked mannoses, to the lysosomal mannosidases, which have either broad (2B1 cleaves &alpha;1,2, &alpha;1,3 and &alpha;1,6 linkages) or narrow specificities (2B2 is specific for &alpha;1,6). GH38 active sites can be quite long and open, and some are sensitive to the polysaccharide substrate structure. For example, Golgi &alpha;-mannosidase II requires the presence of a GlcNAc residue some five residues away from the cleavage site, while lysosomal mannosidases do not have that requirement <cite>1 11</cite>.  
 +
There have been GH38 mannosidases identified in a number of different localizations, classed into subfamilies with different substrate specificities and biochemical properties, and, presumably, different physiological roles. The Golgi enzyme is identified as 2A1 (Class 2, A for Golgi, enzyme 1). Lysosomal GH38 mannosidases are indicated by 'B' (2B1, 2B2) and those likely existing in the cytoplasm by 'C'.
 +
Physiological roles have been identified for the Golgi enzyme in the protein N-glycosylation pathway and lysosomal mannosidases in general are likely to be involved in scavenging of degraded glycoproteins. Roles for the cytoplasmic subclass have not been identified definitively, but they may play a role in protein recognition or signalling.
  
 
== Kinetics and Mechanism ==
 
== Kinetics and Mechanism ==
GH38 enzymes operate by the conventional Koshland double-displacement retaining mechanism.  
+
GH38 enzymes operate by the conventional Koshland double-displacement retaining mechanism. This was initially determined by covalent intermediate trapping with the Jack Bean homologue <cite>3</cite> and later confirmed by structural analysis of covalent intermediates <cite>5</cite>
There have been GH38 mannosidases identified in a number of different localizations, classed into subfamilies with different substrate specificities and biochemical properties, and, presumably, different physiological roles. The Golgi enzyme is identified as 2A1 (Class 2, A for Golgi, enzyme 1). Lysosomal GH38 mannosidases are indicated by 'B' (2B1, 2B2) and those likely existing in the cytoplasm by 'C'.
 
Physiological roles have been identified for the Golgi enzyme in the protein N-glycosylation pathway and lysosomal mannosidases in general are likely to be involved in scavenging of degraded glycoproteins. Roles for the cytoplasmic subclass have not been identified definitively, but they may play a role in protein recognition or signalling.
 
  
 
== Catalytic Residues ==
 
== Catalytic Residues ==
Line 37: Line 37:
 
The crystal structure of the GH38 domain of ''Drosophila'' Golgi &alpha;-mannosidase II <cite>1</cite> has been determined in complex with a large number of inhibitors and catalytic intermediate mimics. Many of these are at very high resolution: 1.2-1.6&Aring; (see <cite>5 6 7 8 9</cite> for examples). An enzyme-substrate complex has also been determined <cite>10</cite>.
 
The crystal structure of the GH38 domain of ''Drosophila'' Golgi &alpha;-mannosidase II <cite>1</cite> has been determined in complex with a large number of inhibitors and catalytic intermediate mimics. Many of these are at very high resolution: 1.2-1.6&Aring; (see <cite>5 6 7 8 9</cite> for examples). An enzyme-substrate complex has also been determined <cite>10</cite>.
 
The crystal structure of bovine lysosomal &alpha;-mannosidase II was determined to 2.7&Aring; resolution indicated interesting low-pH activation effects <cite>4</cite> .
 
The crystal structure of bovine lysosomal &alpha;-mannosidase II was determined to 2.7&Aring; resolution indicated interesting low-pH activation effects <cite>4</cite> .
 +
The GH38 fold has been referred to as the "mannosidase fold". It is one large (approximately 1000-residue) globular domain, which can be roughly divided by secondary structure into an &alpha;/&beta; portion and an all-&beta; region. The former portion contains the active site, anchored by a Zn atom, which forms an integral part of the -1 site, interacting with the saccharide and helping to induce substrate distortion <cite>1</cite>.
  
 
== Family Firsts ==
 
== Family Firsts ==

Revision as of 13:09, 21 August 2009


Glycoside Hydrolase Family GH38
Clan GH-x
Mechanism retaining
Active site residues known
CAZy DB link
http://www.cazy.org/fam/GH38.html

Substrate specificities

GH38 enzymes are Class II α-mannosidases. They range in breadth of specificity from the Golgi α-mannosidase (2A1), which has a dual specificity for α1,6 and α1,3-linked mannoses, to the lysosomal mannosidases, which have either broad (2B1 cleaves α1,2, α1,3 and α1,6 linkages) or narrow specificities (2B2 is specific for α1,6). GH38 active sites can be quite long and open, and some are sensitive to the polysaccharide substrate structure. For example, Golgi α-mannosidase II requires the presence of a GlcNAc residue some five residues away from the cleavage site, while lysosomal mannosidases do not have that requirement [1, 2]. There have been GH38 mannosidases identified in a number of different localizations, classed into subfamilies with different substrate specificities and biochemical properties, and, presumably, different physiological roles. The Golgi enzyme is identified as 2A1 (Class 2, A for Golgi, enzyme 1). Lysosomal GH38 mannosidases are indicated by 'B' (2B1, 2B2) and those likely existing in the cytoplasm by 'C'. Physiological roles have been identified for the Golgi enzyme in the protein N-glycosylation pathway and lysosomal mannosidases in general are likely to be involved in scavenging of degraded glycoproteins. Roles for the cytoplasmic subclass have not been identified definitively, but they may play a role in protein recognition or signalling.

Kinetics and Mechanism

GH38 enzymes operate by the conventional Koshland double-displacement retaining mechanism. This was initially determined by covalent intermediate trapping with the Jack Bean homologue [3] and later confirmed by structural analysis of covalent intermediates [4]

Catalytic Residues

Both catalytic side chains are Asp residues. The nucleophile Asp204 (Golgi α-mannosidase II numbering) was inferred from previous studies with Jack Bean mannosidase [3] and confirmed in the crystal structures of covalent intermediates [5]. Mutagenesis studies implicated Asp341 as the likely acid-base catalyst.

Three-dimensional structures

The crystal structure of the GH38 domain of Drosophila Golgi α-mannosidase II [1] has been determined in complex with a large number of inhibitors and catalytic intermediate mimics. Many of these are at very high resolution: 1.2-1.6Å (see [4, 6, 7, 8, 9] for examples). An enzyme-substrate complex has also been determined [10]. The crystal structure of bovine lysosomal α-mannosidase II was determined to 2.7Å resolution indicated interesting low-pH activation effects [11] . The GH38 fold has been referred to as the "mannosidase fold". It is one large (approximately 1000-residue) globular domain, which can be roughly divided by secondary structure into an α/β portion and an all-β region. The former portion contains the active site, anchored by a Zn atom, which forms an integral part of the -1 site, interacting with the saccharide and helping to induce substrate distortion [1].

Family Firsts

First sterochemistry determination
First catalytic nucleophile identification
Jack Bean mannosidase [3]
First general acid/base residue identification
Golgi α-mannosidase II covalent intermediate stabilization [5]
First 3-D structure
Golgi α-mannosidase II [1]

References

  1. van den Elsen JM, Kuntz DA, and Rose DR. (2001). Structure of Golgi alpha-mannosidase II: a target for inhibition of growth and metastasis of cancer cells. EMBO J. 2001;20(12):3008-17. DOI:10.1093/emboj/20.12.3008 | PubMed ID:11406577 [1]
  2. Park C, Meng L, Stanton LH, Collins RE, Mast SW, Yi X, Strachan H, and Moremen KW. (2005). Characterization of a human core-specific lysosomal {alpha}1,6-mannosidase involved in N-glycan catabolism. J Biol Chem. 2005;280(44):37204-16. DOI:10.1074/jbc.M508930200 | PubMed ID:16115860 [11]
  3. Howard S, He S, and Withers SG. (1998). Identification of the active site nucleophile in jack bean alpha-mannosidase using 5-fluoro-beta-L-gulosyl fluoride. J Biol Chem. 1998;273(4):2067-72. DOI:10.1074/jbc.273.4.2067 | PubMed ID:9442045 [3]
  4. Shah N, Kuntz DA, and Rose DR. (2003). Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms. Biochemistry. 2003;42(47):13812-6. DOI:10.1021/bi034742r | PubMed ID:14636047 [5]
  5. Numao S, Kuntz DA, Withers SG, and Rose DR. (2003). Insights into the mechanism of Drosophila melanogaster Golgi alpha-mannosidase II through the structural analysis of covalent reaction intermediates. J Biol Chem. 2003;278(48):48074-83. DOI:10.1074/jbc.M309249200 | PubMed ID:12960159 [2]
  6. Kawatkar SP, Kuntz DA, Woods RJ, Rose DR, and Boons GJ. (2006). Structural basis of the inhibition of Golgi alpha-mannosidase II by mannostatin A and the role of the thiomethyl moiety in ligand-protein interactions. J Am Chem Soc. 2006;128(25):8310-9. DOI:10.1021/ja061216p | PubMed ID:16787095 [6]
  7. Kumar NS, Kuntz DA, Wen X, Pinto BM, and Rose DR. (2008). Binding of sulfonium-ion analogues of di-epi-swainsonine and 8-epi-lentiginosine to Drosophila Golgi alpha-mannosidase II: the role of water in inhibitor binding. Proteins. 2008;71(3):1484-96. DOI:10.1002/prot.21850 | PubMed ID:18076078 [7]
  8. Zhong W, Kuntz DA, Ember B, Singh H, Moremen KW, Rose DR, and Boons GJ. (2008). Probing the substrate specificity of Golgi alpha-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant. J Am Chem Soc. 2008;130(28):8975-83. DOI:10.1021/ja711248y | PubMed ID:18558690 [8]
  9. Fiaux H, Kuntz DA, Hoffman D, Janzer RC, Gerber-Lemaire S, Rose DR, and Juillerat-Jeanneret L. (2008). Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site. Bioorg Med Chem. 2008;16(15):7337-46. DOI:10.1016/j.bmc.2008.06.021 | PubMed ID:18599296 [9]
  10. Shah N, Kuntz DA, and Rose DR. (2008). Golgi alpha-mannosidase II cleaves two sugars sequentially in the same catalytic site. Proc Natl Acad Sci U S A. 2008;105(28):9570-5. DOI:10.1073/pnas.0802206105 | PubMed ID:18599462 [10]
  11. Heikinheimo P, Helland R, Leiros HK, Leiros I, Karlsen S, Evjen G, Ravelli R, Schoehn G, Ruigrok R, Tollersrud OK, McSweeney S, and Hough E. (2003). The structure of bovine lysosomal alpha-mannosidase suggests a novel mechanism for low-pH activation. J Mol Biol. 2003;327(3):631-44. DOI:10.1016/s0022-2836(03)00172-4 | PubMed ID:12634058 [4]

All Medline abstracts: PubMed